Free Sample: Medical Cannabis Clinician Brief on Neuropathic Pain (Nationwide Edition, 1-page PDF)

Not sure whether these briefs are for you? Start here, at no cost.

Inside:

- The 2017 National Academies conclusion on chronic pain, quoted word for word

- Seven verified sources:

- the National Academies report

- the 2026 Cochrane review Cannabis-based medicines for chronic neuropathic pain in adults

- three PubMed-indexed studies and reviews

- NCCIH's cannabis overview

- Granny Storm Crow's List (patient-community index, for orientation only)

- Honest notes on how to read the evidence, practical visit prompts, and interaction-checker links

If it's useful, the full Top 10 Conditions in Older Adults pack takes the same approach for ten conditions and adds geriatric considerations, a state-rules note on every brief and a 50-state + DC program table.

Enter $0, or pay what you like to support the work.

Education only. These briefs are a research-navigation aid. They are not medical, legal or prescribing advice. They do not diagnose, prescribe, recommend products, set doses or titration, or give drug-interaction verdicts. Cited titles and conclusions are summarized for orientation only. Read the original sources before relying on any of them. Clinical decisions remain with the treating clinician. Confirm all laws and program rules on official state sites. For use with licensed, state-regulated medical cannabis programs only.

Sources include the National Academies of Sciences, Engineering, and Medicine (2017), Cochrane reviews, studies indexed in PubMed, NIH pages (NCCIH, NCI and others), the National Conference of State Legislatures (NCSL), official state program sites, and Granny Storm Crow's List (a patient-community research index, for orientation only). This is an independent guide and is not endorsed by any cited source. Prepared by Annie Romelfanger, author of Medical Cannabis Handbook: A Friendly Guide to Safe, Simple Healing. Last reviewed: October 2026. Corrections: romelfanger@proton.me.